Report: FDA panel wants more extensive data, quality of life outcomes for vaginal mesh products

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Feb 16, 2019 at 12:12 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,730
    Likes Received:
    3
    via Longer, more extensive studies and a focus on subjective quality of life outcomes were among the top agreed upon recommendations for future trials studying transvaginal mesh implants used for treating pelvic organ prolapse, according to a MedTech Dive report covering the recently held FDA transvaginal mesh advisory panel.

    article source